supplementary table 4 from PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Authors:
  • ARAnne de la Rochefordiere
    Anne de la Rochefordiere
  • MKMaud Kamal
    Maud Kamal
  • AFAnne Floquet
    Anne Floquet
  • LTLaurence Thomas
    Laurence Thomas
  • PPPeter Petrow
    Peter Petrow
  • TPThierry Petit
    Thierry Petit
  • MPMarius Pop
    Marius Pop
  • MFMichel Fabbro
    Michel Fabbro
  • CKChristine Kerr
    Christine Kerr
  • FJFlorence Joly
    Florence Joly
  • ESEmmanuel Sevin
    Emmanuel Sevin
  • SMSophie Maillard
    Sophie Maillard

Abstract
Supplementary table 4. Multivariate analysis for Complete Clinical Response and Figo stage